Search results for
Pharmaceuticals
-
October 26, 2026
'India needs reimbursement mechanisms, predictable policies to drive pharma innovation': OPPI chief Anil Matai
Anil Matai, Director General of the Organisation of Pharmaceutical Producers of India, discusses medicine pricing, cancer care costs, patient assistance programmes and more
-
October 21, 2026
Why recognising a generic drug for Spinal Muscular Atrophy is significant
The Department of Health's adoption of affordable generic Risdiplam for Spinal Muscular Atrophy marks a major victory for patient access and public health
-
October 20, 2026
OPINION | How HR tech can help India’s pharma industry build a more efficient workforce
Connecting attendance, performance, and learning data allows pharma leaders to make evidence-based decisions and address skill gaps effectively
-
September 25, 2026
Indian pharma sector to see 11-13% growth, but margins face pressure
The Indian pharma sector is projected to experience strong revenue growth of 11-13% this fiscal, propelled by a significant upswing in exports and robust domestic demand
-
July 22, 2026
Single-speciality hospitals surge ahead as medical device makers battle global headwinds
Cancer, childcare chains power health care growth in India while device firms get the scalpel treatment from spikes in tariffs and costs
-
March 11, 2026
Will your medicines get costlier because of Iran war? Indian Pharma exports could see Rs 5000 crore in losses
Rising raw material costs and freight charges due to the war in Iran are now poised to increase medicine prices in India, impacting both local manufacturing and exports to the Middle East and North Africa
-
September 26, 2025
Be afraid, be very afraid: As Trump walks the (threat) talk, India should be worried
What India perhaps had not calculated in the midst of it all were two developments. One, the swift moves by other nations in the face of Trump’s tariff threats, and two, Trump’s own domestic compulsions
-
September 26, 2025
Pharma Paradox: When strong business doesn't mean strong stocks
Despite impressive earnings and strong exports, the recent Trump tariffs on India's pharmaceutical sector pushed major sectoral stocks down, including Sun Pharma, Cipla, and Dr Reddy's